TY - JOUR
T1 - Soluble HLA-G
T2 - Are they clinically relevant?
AU - Pistoia, Vito
AU - Morandi, Fabio
AU - Wang, Xinhui
AU - Ferrone, Soldano
PY - 2007/12
Y1 - 2007/12
N2 - HLA-G is a non-classical HLA-class Ib molecule with multiple immunoregulatory properties. Its main function in physiological conditions is to abrogate maternal NK cell activity against foetal tissue and to establish immune tolerance at maternal-foetal interface. HLA-G is expressed not only as a membrane bound molecule on the surface of cells, but also as a soluble moiety in body fluids. The major isoforms of HLA-G present in serum are soluble HLA-G1 and HLA-G5 which are generated by shedding or proteolytic cleavage of the membrane bound isoform and by secretion of a soluble isoform, respectively. Here we review the data about soluble HLA-G (sHLA-G) serum levels in different pathological conditions, including immune-mediated disorders, transplantation and malignancies. In particular, we focus on sHLA-G expression and function in human neuroblastoma, a pediatric tumor, with special emphasis on a novel potential immuno escape mechanism utilized by NB to instruct monocytes to produce and release sHLA-G. Finally, the potential clinical relevance of sHLA-G serum levels is discussed.
AB - HLA-G is a non-classical HLA-class Ib molecule with multiple immunoregulatory properties. Its main function in physiological conditions is to abrogate maternal NK cell activity against foetal tissue and to establish immune tolerance at maternal-foetal interface. HLA-G is expressed not only as a membrane bound molecule on the surface of cells, but also as a soluble moiety in body fluids. The major isoforms of HLA-G present in serum are soluble HLA-G1 and HLA-G5 which are generated by shedding or proteolytic cleavage of the membrane bound isoform and by secretion of a soluble isoform, respectively. Here we review the data about soluble HLA-G (sHLA-G) serum levels in different pathological conditions, including immune-mediated disorders, transplantation and malignancies. In particular, we focus on sHLA-G expression and function in human neuroblastoma, a pediatric tumor, with special emphasis on a novel potential immuno escape mechanism utilized by NB to instruct monocytes to produce and release sHLA-G. Finally, the potential clinical relevance of sHLA-G serum levels is discussed.
KW - HLA-G
KW - Immune escape
KW - Immune-mediated diseases
KW - Transplantation
KW - Tumors
UR - http://www.scopus.com/inward/record.url?scp=35948961915&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35948961915&partnerID=8YFLogxK
U2 - 10.1016/j.semcancer.2007.07.004
DO - 10.1016/j.semcancer.2007.07.004
M3 - Article
C2 - 17825579
AN - SCOPUS:35948961915
SN - 1044-579X
VL - 17
SP - 469
EP - 479
JO - Seminars in Cancer Biology
JF - Seminars in Cancer Biology
IS - 6
ER -